Role of adenosine signaling in the pathogenesis of head and neck cancer.
Reza KhayamiYounes ToroghianAmirhossein BahreyniAfsane BahramiMajid KhazaeiGordon A FernsSafieh EbrahimiAnvar SoleimaniHamid FiujiSoodabeh ShahidsalesSeyed Mahdi HassanianPublished in: Journal of cellular biochemistry (2018)
The concentrations of adenosine may increase under ischemic conditions in the tumor microenvironment, and then it enters the systemic circulation. Adenosine controls cancer progression and responses to therapy by regulating angiogenesis, cell survival, apoptosis, cell proliferation, and metastases in tumors. Hence, adenosine metabolism, adenosine-generating enzymes, and adenosine signaling are potentially novel therapeutic targets in a wide range of pathological conditions, including cerebral and cardiac ischemic diseases, inflammatory disorders, immunomodulatory disorders, and, of special interest in this review, cancer. This review summarizes the role of adenosine in the pathogenesis of head and neck cancer for a better understanding of how this may be applied to treating this type of cancer.
Keyphrases
- protein kinase
- papillary thyroid
- cell proliferation
- squamous cell
- oxidative stress
- ischemia reperfusion injury
- endoplasmic reticulum stress
- stem cells
- left ventricular
- heart failure
- signaling pathway
- cerebral ischemia
- young adults
- bone marrow
- subarachnoid hemorrhage
- lymph node metastasis
- cell cycle arrest
- pi k akt
- replacement therapy